SCIENTIFIC HUB

Follow the evidence.

107.346 articles found

Source record

A glucan from Ganoderma lucidum: Structural characterization and the anti-inflammatory effect on Parkinson's disease via regulating dysfunctions of intestinal microecology and inhibiting TLR4/MyD88/NF-κB signaling pathway.

Chen L, Ling Y, Sun J, Zhou S, Xiao Y, Zou X, Yang X, Zhang Y.

J Ethnopharmacol · 2025-02-04

DOI: 10.1016/j.jep.2025.119446PMID: 39914690

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Antiplatelet therapy as a novel approach in Parkinson's disease: Repositioning Ticagrelor to alleviate rotenone-induced parkinsonism via modulation of ER stress, apoptosis, and autophagy.

Muneeb M, Abdallah DM, El-Abhar HS, Wadie W, Ahmed KA, Abul Fadl YS.

Neuropharmacology · 2025-02-04

DOI: 10.1016/j.neuropharm.2025.110346PMID: 39914616

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Polygenic scores for disease risk are not associated with clinical outcomes in Parkinson’s disease

Tan MM, Iwaki H, Bandres-Ciga S, Sosero Y, Shoai M, Brockmann K, Williams NM, Alcalay RN, Maple-Grødem J, Alves G, Tysnes O, Auinger P, Eberly S, Heutink P, Simon DK, Kieburtz K, Hardy J, Williams-Gray CH, Grosset DG, Corvol J, Gan-Or Z, Toft M, Pihlstrøm L.

· 2025-02-03

DOI: 10.1101/2025.01.31.25321395

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.